3,586 Shares in Cigna Group $CI Purchased by Quantitative Investment Management LLC

Quantitative Investment Management LLC acquired a new stake in Cigna Group (NYSE:CIFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 3,586 shares of the health services provider’s stock, valued at approximately $988,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CI. BlackRock Inc. grew its holdings in Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after buying an additional 840,098 shares in the last quarter. State Street Corp increased its holdings in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after purchasing an additional 224,122 shares during the period. Dodge & Cox raised its stake in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares in the last quarter. GQG Partners LLC lifted its holdings in Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares during the period. Finally, Geode Capital Management LLC grew its position in Cigna Group by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock valued at $1,658,055,000 after buying an additional 48,474 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 23,012 shares of company stock valued at $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Finally, Barclays increased their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average target price of $339.45.

Check Out Our Latest Stock Analysis on CI

Cigna Group Stock Performance

Shares of CI opened at $282.90 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm’s 50 day moving average is $283.40 and its 200-day moving average is $281.14. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The stock has a market capitalization of $74.75 billion, a P/E ratio of 11.70, a P/E/G ratio of 0.95 and a beta of 0.31.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.